期刊文献+

化疗栓塞术联合射频消融治疗肝癌的疗效分析 被引量:12

化疗栓塞术联合射频消融治疗肝癌的疗效分析
暂未订购
导出
摘要 目的探讨经肝动脉化疗栓塞术(TACE)联合射频消融(RFA)对原发性肝癌的治疗效果。方法回顾性分析2008年4月~2010年7月收治的72例肝细胞癌患者的临床资料,根据治疗方法分为TACE联合RFA组(30例)、TACE组(42例)。TACE联合RFA组行TACE联合RFA治疗,TACE组行单纯TACE治疗。两组治疗结束后通过随访、影像学检查及血液分析进行评价。结果 TACE组患者的肿瘤总缩小率和肿瘤完全坏死率分别为49.8%和23.8%,1、2年生存率分别为69.0%和42.9%。TACE联合RFA组的分别为76.6%、53.4%,86.7%和76.0%,TACE联合RFA组的生存率明显高于单纯TACE组(P<0.05)。结论 TACE联合RFA治疗原发性肝癌可以使病灶得到有效控制,减少肿瘤复发,显著提高生存率,延长患者的生存期。 Objective To investigate the effect of transcatheter hepatic arterial chemoembolization (TACE) combined with radiofrequency ablation (RFA) in treatment of hepatocellular carcinoma. Methods A retrospective analysis was pertbrmed of 72 patients with hepatocellular carcinoma who received different treatments during April 2008-July 2010. The patients were divided into 2 groups: 30 patients in TACE + RFA group, and 42 patients in TACE group. All patients were analyzed after treatment by follow-up, imaging examine and their blood biochemical tests. Results The rate of tumor shrinkage and necrosis was 49.8% and 23.8%,the survival rate in 1,2years were 69.0% and 42.9%, while the TACE+RFA group was 76.6%, 53.4%, 86.7% and 76.0%,respectively. The survival rates in the synthetic therapy group were significantly higher than in the TACE group (P〈0.05). Conclusion TACE combined with RFA can control lesions enlargement and reduce recurrent ,significantly increase survival rate and survival period in patients with hepatocellular carcinoma.
作者 李志军 钟薇
出处 《当代医学》 2013年第3期5-7,共3页 Contemporary Medicine
关键词 肝癌 肝动脉 栓塞 治疗性 射频消融 Hepatic carcinoma Hepatic artery Embolization,therapeutic Radiofrequency ablation
  • 相关文献

参考文献11

  • 1陆骊工,胡宝山,李勇,罗鹏飞.微波消融联合TACE治疗原发性肝癌的临床研究[J].实用放射学杂志,2008,24(7):957-959. 被引量:20
  • 2Wallace S,Goldstein HM.lntravascular occlusive therapy, use ofinterventional radiology in cancer patients[J].Postgrad Med, 1 976,59(2). 141 -146.
  • 3Takaki H , Yamakado K,Uraki J , et al. Radiofrequency ablationcombined with chemoembolization for the treatment of hepatocellular carcinomaslarger than 5 cm[J].J Vase Interv Radiol,2009,20(2).21 7-224.
  • 4Murakami T.lshimaru H, Sakamoto I,et al .Percutaneous radiofrequencyablation and transcatheter arterial chemoembolization for hypervascularhepatocellular carcinoma .rate and risk factors for local recurrence[J]. CardiovascIntervent Radio丨,2007,30(4): 696-704.
  • 5Takaki H., Yamakado K.Nakatsuka A,et al .Radiofrequency ablationcombined with chemoembolization for the treatment of hepatocellular carcinomas5 cm or smalle:risk factors for local tumor progression[J],J Vase IntervRadiol, 2007, 1 8(7): 856-861 .
  • 6朱敏,徐浩.TACE联合无水酒精碘油乳剂注射治疗肝细胞癌的新进展[J].当代医学,2012,18(6):119-122. 被引量:13
  • 7Nishimine K,Uchida H , Matsuo N, et al. Segmental transarterialchemoembolization with Lipiodol mixed with arvticancer drugs for nonresectablehepatocellular carcinoma:follow-up CT and therapeutic「esults[J].CancerChemother Pharmacol. 1 994,33(Suppl). S60-S68.
  • 8韦传军,李彦豪,陈勇,何晓峰,卢伟,曾庆乐,张超.肝动脉化疗栓塞术后联合射频热凝治疗大肝癌[J].介入放射学杂志,2005,14(3):246-248. 被引量:26
  • 9王亚军,朱研,李铎.肝癌经皮局部消融治疗[J].中国现代普通外科进展,2004,7(1):4-6. 被引量:2
  • 10王建华.肝癌综合介入治疗的现状[J].中华肝脏病杂志,2005,13(10):721-723. 被引量:80

二级参考文献54

共引文献131

同被引文献113

引证文献12

二级引证文献63

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部